Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Embody vs Sumbare Wellness

Embody
Graded #52

Higher grade

vs+14.600000000000001
Sumbare Wellness
Graded #281

Lower grade

The verdict

Embody takes it — 76.5/100 to 61.9/100.

Embody grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEmbody +22
88
66
Dose & formulationEmbody +11
83
72
Clinical oversightEmbody +27
83
56
Labs & monitoringEmbody +2
54
52
FulfillmentEmbody +34
93
59
Contract termsSumbare Wellness +36
25
61
Embody · left barSumbare Wellness · right bar

The numbers

MetricEmbodySumbare Wellness
WeighScore76.5/10061.9/100
GradeCC
Scorecard rank#52#281
Semaglutide$79/mo (all doses, promotional rate, compounded)$199/mo (all doses, compounded)
Tirzepatide$129/mo (all doses, promotional rate, compounded)$199/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Embody

Graded #52 · C

Strengths

  • Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Where it loses points

  • The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Sumbare Wellness

Graded #281 · C

Strengths

  • One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
  • Charges nothing if a provider does not approve you
  • Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
  • Publishes a named legal entity, a US mailing address and a working phone number
  • Pre-screening quiz is short and asks your goal before any medical question

Where it loses points

  • Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
  • Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
  • Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
  • No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
  • Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard